Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00418457 · ClinicalTrials.gov registry record · Phase 3
Regional Anesthesia and Breast Cancer Recurrence
A Phase 3 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,108
- Enrollment target
NCT00418457 is a Phase 3 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 2,108 participants.
The verdict
NCT00418457, a Phase 3 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,108 participants
- Enrollment target
Study Summary
In this multi-center trial, Stage 1-3 patients having mastectomies or isolated lumpectomy with axillary node dissection will be randomly assigned to thoracic epidural or paravertebral anesthesia/analgesia, or to general anesthesia and morphine analgesia. Participants will be followed for up to 10 years to determine the rate of cancer recurrence or metastasis.
Interventions
- DRUG General anesthesia and opioids
- DRUG Regional analgesia and propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,108 participants |
| Start Date | 2007-01 |
| Est. Completion | 2019-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00418457
The ClinicalTrials.gov registry entry for NCT00418457 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which General anesthesia and opioids is the first listed.
NCT00418457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00418457 about?
NCT00418457 is a clinical study titled "Regional Anesthesia and Breast Cancer Recurrence". In this multi-center trial, Stage 1-3 patients having mastectomies or isolated lumpectomy with axillary node dissection will be randomly assigned to thoracic epidural or paravertebral anesthesia/analgesia, or to general anesthesia and morphine analgesia. Participants will be followed for up to 10 ye...
What is the current status of trial NCT00418457?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,108 participants. The study started on 2007-01. Estimated completion is 2019-12.
What interventions are being tested in trial NCT00418457?
The interventions under investigation include: General anesthesia and opioids (DRUG), Regional analgesia and propofol (DRUG).
Who is sponsoring clinical trial NCT00418457?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.